金域医学：预计2025年年度实现归属于上市公司股东的净利润为-13000万元到-19000万元

Group 1 - The company, Kingmed Diagnostics, expects to achieve a net profit attributable to shareholders of the listed company in 2025 ranging from -130 million to -190 million yuan, indicating a projected loss [2] - This represents an improvement in loss compared to the previous year, with a reduction in loss estimated between 191.24 million and 251.24 million yuan year-on-year [2]